SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-18-006977
Filing Date
2018-02-09
Accepted
2018-02-09 16:40:32
Documents
95
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tv484831_10q.htm 10-Q 750534
2 EXHIBIT 31.1 tv484831_ex31-1.htm EX-31.1 11994
3 EXHIBIT 31.2 tv484831_ex31-2.htm EX-31.2 11918
4 EXHIBIT 32.1 tv484831_ex32-1.htm EX-32.1 4241
5 EXHIBIT 32.2 tv484831_ex32-2.htm EX-32.2 4314
  Complete submission text file 0001144204-18-006977.txt   6707938

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT eltp-20171231.xml EX-101.INS 1603449
7 XBRL TAXONOMY EXTENSION SCHEMA eltp-20171231.xsd EX-101.SCH 69667
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE eltp-20171231_cal.xml EX-101.CAL 40374
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE eltp-20171231_def.xml EX-101.DEF 403831
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE eltp-20171231_lab.xml EX-101.LAB 451358
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eltp-20171231_pre.xml EX-101.PRE 467098
Mailing Address 165 LUDLOW AVENUE NORTHVALE NJ 07647
Business Address 165 LUDLOW AVENUE NORTHVALE NJ 07647 2017502646
ELITE PHARMACEUTICALS INC /NV/ (Filer) CIK: 0001053369 (see all company filings)

IRS No.: 223542636 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-15697 | Film No.: 18592346
SIC: 2834 Pharmaceutical Preparations